Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
Publication
, Journal Article
Kumar, SK; Callander, NS; Adekola, K; Anderson, L; Baljevic, M; Campagnaro, E; Castillo, JJ; Chandler, JC; Costello, C; Efebera, Y; Faiman, M ...
Published in: J Natl Compr Canc Netw
December 2, 2020
Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2, 2020
Volume
18
Issue
12
Start / End Page
1685 / 1717
Location
United States
Related Subject Headings
- Plasmacytoma
- Plasma Cells
- Oncology & Carcinogenesis
- Multiple Myeloma
- Medical Oncology
- Humans
- Bone Marrow
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, S. K., Callander, N. S., Adekola, K., Anderson, L., Baljevic, M., Campagnaro, E., … Kumar, R. (2020). Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw, 18(12), 1685–1717. https://doi.org/10.6004/jnccn.2020.0057
Kumar, Shaji K., Natalie S. Callander, Kehinde Adekola, Larry Anderson, Muhamed Baljevic, Erica Campagnaro, Jorge J. Castillo, et al. “Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw 18, no. 12 (December 2, 2020): 1685–1717. https://doi.org/10.6004/jnccn.2020.0057.
Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, et al. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685–717.
Kumar, Shaji K., et al. “Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.” J Natl Compr Canc Netw, vol. 18, no. 12, Dec. 2020, pp. 1685–717. Pubmed, doi:10.6004/jnccn.2020.0057.
Kumar SK, Callander NS, Adekola K, Anderson L, Baljevic M, Campagnaro E, Castillo JJ, Chandler JC, Costello C, Efebera Y, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Kang Y, Hultcrantz M, Larson S, Liedtke M, Martin T, Omel J, Shain K, Sborov D, Stockerl-Goldstein K, Weber D, Keller J, Kumar R. Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Dec 2;18(12):1685–1717.
Published In
J Natl Compr Canc Netw
DOI
EISSN
1540-1413
Publication Date
December 2, 2020
Volume
18
Issue
12
Start / End Page
1685 / 1717
Location
United States
Related Subject Headings
- Plasmacytoma
- Plasma Cells
- Oncology & Carcinogenesis
- Multiple Myeloma
- Medical Oncology
- Humans
- Bone Marrow
- 4203 Health services and systems
- 3211 Oncology and carcinogenesis